Macrocyclic isoquinoline peptides are disclosed having the general formula:A compound of formula I: ##STR00001## wherein R.sub.1 to R.sub.9, Q and W are described in the description. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.